AzTrials
AzTrials

HospitalismIHPNCT06577870

Immersive Sensory Projections for Hospitalized Patients

A study testing Hospitalization in intensive care or continuing care unit in people with Hospitalism, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit/continuing care unit. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hospitalism
What is being tested?
Hospitalization in intensive care or continuing care unit
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
208 participants
Where
1 siteFrance
Study dates
20 May 2025to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years ;
  • Patient hospitalized in intensive care or continuing care unit for an estimated minimum of 48 hours;
  • Patient hospitalized for a medical indication (including in the pre-surgical phase) or in the post-surgical phase;
  • Patient or support person who speaks and understands French, has understood the research procedures and is able to complete the questionnaires;
  • For women of childbearing age (non-menopausal), even for those on contraception: negative pregnancy test (urinary); If positive: completed by a biological test;
  • Patient or trusted support person having been informed and having signed an informed consent form to participate in the study.

Who cannot join

  • Deaf or blind patient;
  • Asthmatic patient with background treatment;
  • Epileptic patient or known history of convulsion;
  • Known allergy or intolerance to essential oils or to a component of essential oils;
  • Patient transferred from another intensive care unit;
  • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
Show all 13Show fewer
  • Breast-feeding or pregnant women;
  • Patient or support person unable to understand information relating to the study (linguistic, psychological, cognitive, etc.);
  • Unconscious patient with no relative or support person present;
  • Homeless patient;
  • Patient with known severe psychiatric illness such as chronic hallucinatory psychosis or paranoid syndrome;
  • Patient participating in or being excluded from another clinical trial;
  • Patient not covered by a social security scheme.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Hôpital Privé Jacques Cartier

    Massy, 91300

    Igor LACOMBAT, MD, igor.lacombat@gmail.com

    Recruiting

Other trials in France

About this study

Official title: Immersive Sensory Projections: Evaluating the Impact of an Immersive Sensory Environment (Visual, Auditory and Olfactory) on Reducing the Overall Discomfort of Patients Hospitalized in the Resuscitation and Continuing Care Units

The purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit/continuing care unit.

Read the detailed description

The IHP trial is multicenter, interventional, prospective, randomized, controlled, open-label study.

The study population consists of adult patients hospitalized in an intensive care or continuing care unit for medical or surgical reasons, conscious or unconscious under mechanical ventilation.

All patients participating in the study will be managed according to usual practices in intensive care and continuing care units. All patients and their relatives will be monitored and supported by the medical team as in normal practice.

The study will be offered to the patient or a close relative/trusted person on admission to hospital.

Conditions
Hospitalism
Being tested
Hospitalization in intensive care or continuing care unit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hospitalization in intensive care or continuing care unitProcedure or surgery

    Hospitalization in intensive care or continuing care unit for medical reasons or surgery, conscious or unconscious under mechanical ventilation. Resuscitation patients are then cared for in a continuing care unit.

Study groups in NCT06577870
Study groupRoleWhat they receive
Immersive sensory projectionsExperimentalPatients will benefit from an immersive sensory environment in the hospital room. This IHP immersive sensory environment consists of the following elements: * light frescoes on the theme of nature, of the canopy type, diffused by a generative circadian cycle. * a soundtrack made up of nature sounds and sounds of life outside the hospital, broadcast in an immersive (moving sounds in the room), random (non-repetitive sounds over time) and generative way. * essential oils
Receives: Procedure: Hospitalization in intensive care or continuing care unit
No immersive sensory projectionsActive comparatorStandard (control) group: Patients will not have any Immersion Health Project-type immersive sensory projection in the hospital room.
Receives: Procedure: Hospitalization in intensive care or continuing care unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. REAnimation Patient Discomfort Questionnaire

    Overall score on the REAnimation Patient Discomfort Questionnaire at the end-of-study visit

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2024
  2. Study start20 May 2025
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Multicenter, interventional, prospective, randomized, controlled study
Masking
None (open label)
Enrolment
208 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06577870
Sponsor's protocol ID
2024-A01322-45
Acronym
IHP
Status last verified
Jun 2026
First submitted
27 Aug 2024
Last updated
16 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Hospitalization in intensive care or continuing care unit in people with Hospitalism, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Igor LACOMBAT, MD (660406554 ext. +33, igor.lacombat@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

REAnimation Patient Discomfort Questionnaire (time frame: 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in